| Pfizer Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500680 |
NSE Symbol : PFIZER |
P/E(TTM) : 32.48 |
|
ISIN Demat : INE182A01018 |
Div & Yield% : 3.29 |
EPS(TTM) : 154.48 |
|
Book Value(₹) : 841.20 |
Market Cap(₹Cr) : 22,956.67 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 642.34 | 603.05 | 591.91 | 537.99 | 588.59 | 562.86 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 642.34 | 603.05 | 591.91 | 537.99 | 588.59 | 562.86 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 41.85 | 67.17 | 217.39 | 42.76 | 43.07 | 41.84 |
| Total Income | 684.19 | 670.22 | 809.30 | 580.75 | 631.66 | 604.70 |
| Total Expenditure | 412.41 | 393.03 | 364.41 | 392.00 | 399.34 | 385.37 |
| PBIDT | 271.78 | 277.19 | 444.89 | 188.75 | 232.32 | 219.33 |
| Interest | 2.13 | 3.25 | 2.69 | 1.51 | 2.10 | 2.11 |
| PBDT | 269.65 | 273.94 | 442.20 | 187.24 | 230.22 | 217.22 |
| Depreciation | 14.28 | 14.41 | 16.40 | 14.80 | 14.99 | 14.60 |
| Tax | 65.49 | 67.39 | 99.06 | 50.10 | 59.89 | 55.05 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.86 | 0.39 | -4.20 | -5.26 | -3.01 | -3.14 |
| Reported Profit After Tax | 189.02 | 191.75 | 330.94 | 127.60 | 158.35 | 150.71 |
| Extra-ordinary Items | 0.00 | 0.00 | 132.61 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 189.02 | 191.75 | 198.33 | 127.60 | 158.35 | 150.71 |
| EPS (Unit Curr.) | 41.32 | 41.91 | 72.34 | 27.89 | 34.61 | 32.94 |
| EPS (Adj) (Unit Curr.) | 41.32 | 41.91 | 72.34 | 27.89 | 34.61 | 32.94 |
| Calculated EPS (Unit Curr.) | 41.32 | 41.91 | 72.34 | 27.89 | 34.61 | 32.94 |
| Calculated EPS (Adj) (Unit Curr.) | 41.32 | 41.91 | 72.34 | 27.89 | 34.61 | 32.94 |
| Calculated EPS (Ann.) (Unit Curr.) | 165.26 | 167.65 | 289.35 | 111.56 | 138.45 | 131.77 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 165.26 | 167.65 | 289.35 | 111.56 | 138.45 | 131.77 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 45.75 | 45.75 | 45.75 | 45.75 | 45.75 | 45.75 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 3,705.12 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 42.31 | 45.96 | 75.16 | 35.08 | 39.47 | 38.97 |
| PBDTM(%) | 41.98 | 45.43 | 74.71 | 34.80 | 39.11 | 38.59 |
| PATM(%) | 29.43 | 31.80 | 55.91 | 23.72 | 26.90 | 26.78 |